Cardiva Medical Inc. | Optimizing Vascular Access Management



[pic]

(note: an additional fee may be required to include an image or logo)

[Your Hospital Name] uses a new medical device to improve patient satisfaction and reduce the use of opioids.

VASCADE MVP® Venous Vascular Closure System following

AF Ablation procedures gets people back on their feet faster, reduces the use of opioids and improves patient satisfaction.

[Your City Name, Date of Release] – [Your Hospital Name] announced today that it is now using a new medical device called the VASCADE MVP®. VASCADE MVP proved superior to Manual Compression in a prospective, multi-center randomized clinical trial called AMBULATE. In the AMBULATE Clinical trial, Time-To-Ambulation, the time after a procedure to the time the patient can walk on his/her own, was reduced by 3.9 hours (64%). With the use of VASCADE MVP, the need to use opioids was reduced by 58% and patient satisfaction increased by 63%.

“[Create a Quote from Your Electrophysiologist

or CEO and Insert Here]”

[Your Hospital Name] distinguishes itself by offering patients the latest technology to deliver high quality patient care while improving patient satisfaction, including a comprehensive Electrophysiology (EP) service line, to treat cardiac arrhythmias including Atrial Fibrillation (AFib). AFib ablation, a common treatment for patients with AFib, is increasing 15% annually. With the recent integration of this new technology, we intend to help patients get back on their feet as quickly and comfortably as possible following an ablation.

[Insert One Paragraph About Your Hospital Here]

VASCADE MVP is a fully integrated, extravascular, bioabsorbable femoral access closure system that is easy to use and leaves no permanent components behind. The system combines Cardiva’s proven proprietary collapsible disc technology and a thrombogenic resorbable collagen patch in an integrated design. It works by placing a small, collapsible mesh disc against the inside of the vessel wall to temporarily stop the bleeding, releasing a collagen patch into the tissue and then removing the mesh disc. The collagen patch expands, providing a mechanical and physiological seal to stop the bleeding, and then absorbs into the body, leaving nothing behind and allowing further access to the vessel if additional procedures are required.

VASCADE MVP only recently gained FDA approval, making [Your Hospital Name] an early adopter. To learn more about the AMBULATE Clinical Trial or the VASCADE MVP, go to .

More about Cardiva Medical

Cardiva Medical is a privately owned medical device company based out of Santa Clara, CA, gaining many accolades for quality, growth and innovation in 2018 alone. Cardiva Medical received the prestigious 2108 Shingo Award for operational excellence, made the INC 5000 list of fastest growing private companies in the US, and gained recognition from Medtech Insights for its value-based healthcare program called the VASCADE Performance Guarantee.

CONTACT: [INCLUDE THE NAME, TELEPHONE NUMBER, AND E-MAIL ADDRESS OF

THE PERSON MEDIA SHOULD CONTACT FOR ADDITIONAL INFORMATION ABOUT

YOUR COMPANY]

LIT 4384 Rev A

-----------------------

YOUR HOSPITAL LOGO HERE

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download